<html>
<head>
<META HTTP-EQUIV="Content-Type" CONTENT="text/html; charset=us-ascii">
<meta name=Generator content="Microsoft Word 10 (filtered)">
<style>
<!--
/* Font Definitions */
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
{font-family:Verdana;
panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman";}
a:link, span.MsoHyperlink
{color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{color:#606420;
text-decoration:underline;}
span.EmailStijl17
{font-family:Tahoma;
color:blue;}
@page Section1
{size:595.3pt 841.9pt;
margin:70.85pt 70.85pt 70.85pt 70.85pt;}
div.Section1
{page:Section1;}
-->
</style>
</head>
<body lang=NL link=blue vlink="#606420">
<div class=Section1>
<p class=MsoNormal><font size=2 color=blue face=Tahoma><span lang=EN-GB
style='font-size:10.0pt;font-family:Tahoma;color:blue'>Our prehospital
ALS-group (MUG) uses etomidate (Hypnomidate®) and rocuronium bromide
(Esmeron®) for RSI in trauma.</span></font></p>
<p class=MsoNormal><font size=2 color=blue face=Tahoma><span lang=EN-GB
style='font-size:10.0pt;font-family:Tahoma;color:blue'> </span></font></p>
<p class=MsoNormal><font size=2 color=blue face=Tahoma><span lang=EN-GB
style='font-size:10.0pt;font-family:Tahoma;color:blue'>Dirk Soulliaert, RN</span></font></p>
<p class=MsoNormal><font size=2 color=blue face=Tahoma><span lang=EN-GB
style='font-size:10.0pt;font-family:Tahoma;color:blue'>Antwerp, Belgium</span></font></p>
<p class=MsoNormal><font size=2 color=blue face=Tahoma><span lang=EN-GB
style='font-size:10.0pt;font-family:Tahoma;color:blue'> </span></font></p>
<p class=MsoNormal style='margin-left:35.4pt'><font size=2 face=Tahoma><span
style='font-size:10.0pt;font-family:Tahoma'>-----Oorspronkelijk bericht-----<br>
<b><span style='font-weight:bold'>Van:</span></b> trauma-list-bounces@trauma.org
[mailto:trauma-list-bounces@trauma.org] <b><span style='font-weight:bold'>Namens
</span></b>Equine Guy<br>
<b><span style='font-weight:bold'>Verzonden:</span></b> dinsdag 6 januari 2004
6:09<br>
<b><span style='font-weight:bold'>Aan:</span></b> </span></font><font size=2
face=Tahoma><span style='font-size:10.0pt;font-family:Tahoma'>trauma-list@trauma.org</span></font><font
size=2 face=Tahoma><span style='font-size:10.0pt;font-family:Tahoma'><br>
<b><span style='font-weight:bold'>Onderwerp:</span></b> RSI methods in Trauma</span></font></p>
<p class=MsoNormal style='margin-left:35.4pt'><font size=3
face="Times New Roman"><span style='font-size:12.0pt'> </span></font></p>
<div>
<p class=MsoNormal style='margin-left:35.4pt'><font size=2 face=Verdana><span
style='font-size:10.0pt;font-family:Verdana'>What RSI meds and procedures are used
in your field? I have noticed that there has been an increase in the use
of Etomidate with pre-hospital folks. We are still trying to get a better
pre-hospital program going on our side, in which our medical director is an
advocate of versed and no paralytic. ( don't ask..... it's driving us nuts ).</span></font></p>
</div>
<div>
<p class=MsoNormal style='margin-left:35.4pt'><font size=2 face=Verdana><span
style='font-size:10.0pt;font-family:Verdana'> </span></font></p>
</div>
<div>
<p class=MsoNormal style='margin-left:35.4pt'><font size=2 face=Verdana><span
style='font-size:10.0pt;font-family:Verdana'>Thanks for the input</span></font></p>
</div>
<div>
<p class=MsoNormal style='margin-left:35.4pt'><font size=2 face=Verdana><span
style='font-size:10.0pt;font-family:Verdana'> </span></font></p>
</div>
<div>
<p class=MsoNormal style='margin-right:0cm;margin-bottom:12.0pt;margin-left:
35.4pt'><font size=2 face=Verdana><span style='font-size:10.0pt;font-family:
Verdana'>DST, NREMT-P/FFIII</span></font></p>
</div>
</div>
</body>
</html>